Develops and manufactures treatments for rare and ultra-rare diseases.
| Title |
|---|
| 【Alexion Japan】Clinical Scientist, Associate Director, R&D Division Full Time · 8+ YOE Tokyo, Japan · Onsite |
| [Alexion] Clinical Research Associate Full Time · 1+ YOE Seoul, Korea · Onsite |
| Key Account Manager, HPP, Würzburg - Dresden Full Time · 3+ YOE Munich, Germany · Onsite |
| 【Alexion Japan】Associate Director, Data Capability Lead Full Time · 8+ YOE Tokyo, Japan · Onsite |
| 【Alexion Japan】GMT Manager, Medical Customer Care（西日本） Full Time · 5+ YOE Tokyo, Japan · Onsite |
| 【Alexion Japan】GMT Manager, Medical Customer Care（東日本） Full Time · 5+ YOE Tokyo, Japan · Onsite |
| Alternance - Market Access (H/F) Full Time Levallois Perret, France · Onsite |
| 【Alexion Japan】Associate Director, Nephrology Marketing Full Time · 5+ YOE Tokyo, Japan · Onsite |
| ［Alexion Japan］Director, Medical Lead, Neurology Full Time · 3+ YOE Tokyo, Japan · Onsite |
| Patient Safety Lead Full Time San Jose, Costa Rica · Onsite |
| Activities | Biopharmaceutical researchDrug developmentPharmaceutical manufacturingClinical trial managementSpecialty medicine commercialization |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Alexion Pharmaceuticals |
| Employees | 5,000 |
| Type | Private |
| Parent Company | AstraZeneca |
| Subsidiaries | LogicBio TherapeuticsAmolyt PharmaSyntimmunePortola PharmaceuticalsAchillion Pharmaceuticals |
| Tagline | Develops and manufactures treatments for rare and ultra-rare diseases. |
| Founded | 1,992 |
| Website | alexion.com |
| Latest Funding Round | Corporate Round |
| Latest Funding Year | 2,021 |
| Latest Funding Amount | 39,000,000,000 |
| Latest Investors | AstraZeneca |